Yuichi Fukushima
Private Equity Investor chez Taiho Ventures LLC
Profil
Yuichi Fukushima joined Taiho ventures in July 2023.
He worked at the Taiho Pharmaceutical for 15 years and his experience includes Taiho medical affairs team for Abraxane (nab-paclitaxel), Keytruda (pembrolizumab) and Yondelis (trabectedin) for 9 years, planning and management of preclinical joint research with academia for 3 years, and corporate strategy planning for 2 years.
He received his Master of Science from Osaka University for his work on a molecular mechanism of thalamocortical axonal branching formation.
Postes actifs de Yuichi Fukushima
| Sociétés | Poste | Début |
|---|---|---|
Taiho Ventures LLC
 Taiho Ventures LLC Investment ManagersFinance Taiho Ventures LLC (Taiho Ventures) is a venture and private equity subsidiary of Taiho Pharmaceutical Co Ltd founded in 2016. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 01/07/2023 |
Formation de Yuichi Fukushima
| Osaka University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Taiho Ventures LLC
Taiho Ventures LLC Investment ManagersFinance Taiho Ventures LLC (Taiho Ventures) is a venture and private equity subsidiary of Taiho Pharmaceutical Co Ltd founded in 2016. The firm is headquartered in Menlo Park, California. | Finance |
